Back to search
FDAFDA · Food and drugs·Recall number D-0360-2019

Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4

Published December 26, 2018 · Recall initiated: December 14, 2018

Summary

FDA records drug Class I recall D-0360-2019, published December 26, 2018 and initiated December 14, 2018. Recalling firm: Results RNA, LLC; Status: Terminated; Reported quantity: 10,297 bottles; Lot: All Lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Results RNA, LLC
Distributor
Nationwide within the United States
Lot
All Lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4 recalled?

Yes. FDA published recall D-0360-2019 on December 26, 2018. Reported hazard: Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver

What should I do if I have this product?

Voluntary: Firm initiated · Telephone